Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proton Vs. Photon Therapy (IMRT) for Cognitive Preservation in IDH Mutant Gliomas
NCT03180502Phase 2Active, not recruiting
- Sponsor
- NRG Oncology
- Start
- Jan 2018
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in glioma (2 arms), sponsored by NRG Oncology. Primary endpoint: Clinical Trial Battery Composite up to 10 years. Started Jan 2018; status: active, not recruiting.
02
Conditions
glioma
Beyond the preview
Go deeper on NCT03180502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180502.